Literature DB >> 8018767

Multiple autoantibody production in a patient with splenic lymphoma.

M Sawamura1, S Yamaguchi, H Murakami, H Amagai, T Matsushima, J Tamura, T Naruse, J Tsuchiya.   

Abstract

We report on a patient with splenic lymphoma of B-cell origin who developed autoimmune hemolytic anemia (AIHA). IgM lambda M-protein, IgM anticardiolipin antibody (ACA), and lupus anticoagulant (LA) were detected in the serum, and direct Coombs' test showed autoantibodies of the IgG1 and IgG2 subclasses on red blood cells (RBC). In in vitro culture, tumor cells isolated from the spleen produced only IgM ACA, which was enhanced by IL-6 but not by IL-4 or IL-5. The levels of ACA and LA decreased after splenectomy and chemotherapy; the strength of the direct Coombs' test, however, did not change. These findings indicated that in this patient the lymphoma cells produced IgM lambda ACA, but not autoantibodies of the IgG1 and IgG2 subclasses against RBC. It was also suggested that IL-6 might at least partially stimulate the production of ACA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018767     DOI: 10.1007/bf01737426

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  24 in total

1.  Primary malignant lymphomas of the spleen. A morphologic and immunohistochemical analysis of 17 cases.

Authors:  S Falk; H J Stutte
Journal:  Cancer       Date:  1990-12-15       Impact factor: 6.860

2.  Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants.

Authors:  V Bellotti; G Gamba; G Merlini; N Montani; E Bucciarelli; M Stoppini; E Ascari
Journal:  Br J Haematol       Date:  1989-10       Impact factor: 6.998

3.  Endogenous interleukin 6 plays an obligatory role in interleukin 4-dependent human IgE synthesis.

Authors:  D Vercelli; H H Jabara; K Arai; T Yokota; R S Geha
Journal:  Eur J Immunol       Date:  1989-08       Impact factor: 5.532

4.  Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations.

Authors:  M H Rosove; M Ismail; B J Koziol; A Runge; C K Kasper
Journal:  Blood       Date:  1986-08       Impact factor: 22.113

5.  Primary non-Hodgkin lymphoma of the spleen.

Authors:  A Brox; J I Bishinsky; G Berry
Journal:  Am J Hematol       Date:  1991-10       Impact factor: 10.047

6.  Role of early splenectomy in malignant lymphomas with prominent splenic involvement (primary lymphomas of the spleen). A study of 59 cases.

Authors:  P Morel; B Dupriez; B Gosselin; P Fenaux; M H Estienne; T Facon; J P Jouet; F Bauters
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

7.  Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: a report of four patients.

Authors:  M Ciaudo; M H Horellou; J Audouin; C De Carbonnieres; J Conard; M Samama
Journal:  Am J Hematol       Date:  1991-12       Impact factor: 10.047

8.  Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus.

Authors:  T Koike; M Sueishi; H Funaki; H Tomioka; S Yoshida
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

9.  MCNU in the treatment of essential thrombocythemia--a pilot study.

Authors:  H Murakami; J Tamura; M Sawamura
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

10.  Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.

Authors:  Z M Sthoeger; M Wakai; D B Tse; V P Vinciguerra; S L Allen; D R Budman; S M Lichtman; P Schulman; L R Weiselberg; N Chiorazzi
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  2 in total

1.  High Incidence of Antiphospholipid Antibodies in Newly Diagnosed Patients With Lymphoma and a Proposed aPL Predictive Score.

Authors:  Smith Kungwankiattichai; Yupa Nakkinkun; Weerapat Owattanapanich; Theera Ruchutrakool
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

2.  Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients.

Authors:  Ratchada Cressey; Saranya Pimpa; Busyamas Chewaskulyong; Nirush Lertprasertsuke; Somchareon Saeteng; Chatchai Tayapiwatana; Watchara Kasinrerk
Journal:  BMC Biotechnol       Date:  2008-02-20       Impact factor: 2.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.